全文获取类型
收费全文 | 30553篇 |
免费 | 4839篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 574篇 |
儿科学 | 893篇 |
妇产科学 | 820篇 |
基础医学 | 3480篇 |
口腔科学 | 745篇 |
临床医学 | 4243篇 |
内科学 | 6537篇 |
皮肤病学 | 880篇 |
神经病学 | 2615篇 |
特种医学 | 1030篇 |
外国民族医学 | 2篇 |
外科学 | 5505篇 |
综合类 | 389篇 |
一般理论 | 13篇 |
预防医学 | 2792篇 |
眼科学 | 948篇 |
药学 | 1794篇 |
3篇 | |
中国医学 | 77篇 |
肿瘤学 | 2120篇 |
出版年
2023年 | 752篇 |
2022年 | 202篇 |
2021年 | 562篇 |
2020年 | 605篇 |
2019年 | 468篇 |
2018年 | 1048篇 |
2017年 | 1012篇 |
2016年 | 951篇 |
2015年 | 950篇 |
2014年 | 1339篇 |
2013年 | 1487篇 |
2012年 | 1457篇 |
2011年 | 1559篇 |
2010年 | 1175篇 |
2009年 | 1216篇 |
2008年 | 1299篇 |
2007年 | 1224篇 |
2006年 | 1286篇 |
2005年 | 1150篇 |
2004年 | 1210篇 |
2003年 | 1143篇 |
2002年 | 991篇 |
2001年 | 895篇 |
2000年 | 771篇 |
1999年 | 777篇 |
1998年 | 387篇 |
1997年 | 326篇 |
1996年 | 276篇 |
1995年 | 285篇 |
1994年 | 239篇 |
1993年 | 232篇 |
1992年 | 582篇 |
1991年 | 562篇 |
1990年 | 477篇 |
1989年 | 538篇 |
1988年 | 520篇 |
1987年 | 488篇 |
1986年 | 461篇 |
1985年 | 484篇 |
1984年 | 324篇 |
1983年 | 298篇 |
1982年 | 214篇 |
1981年 | 188篇 |
1979年 | 262篇 |
1978年 | 202篇 |
1977年 | 172篇 |
1976年 | 180篇 |
1974年 | 191篇 |
1973年 | 208篇 |
1971年 | 170篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
2.
3.
Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: a focus group study
下载免费PDF全文
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
4.
5.
6.
Archie L. Overmann DesRaj M. Clark Panagiotis Tsagkozis Rikard Wedin Jonathan A. Forsberg 《Journal of orthopaedic research》2020,38(10):2149-2156
Treatment decisions in patients with metastatic bone disease rely on accurate survival estimation. We developed the original PATHFx models using expensive, proprietary software and now seek to provide a more cost-effective solution. Using open-source machine learning software to create PATHFx version 2.0, we asked whether PATHFx 2.0 could be created using open-source methods and externally validated in two unique patient populations. The training set of a well-characterized, database records of 189 patients and the bnlearn package within R Version 3.5.1 (R Foundation for Statistical Computing), was used to establish a series of Bayesian belief network models designed to predict survival at 1, 3, 6, 12, 18, and 24 months. Each was externally validated in both a Scandinavian (n = 815 patients) and a Japanese (n = 261 patients) data set. Brier scores and receiver operating characteristic curves to assessed discriminatory ability. Decision curve analysis (DCA) evaluated whether models should be used clinically. DCA showed that the model should be used clinically at all time points in the Scandinavian data set. For the 1-month time point, DCA of the Japanese data set suggested to expect better outcomes assuming all patients will survive greater than 1 month. Brier scores for each curve demonstrate that the models are accurate at each time point. Statement of Clinical Significance: we successfully transitioned to PATHFx 2.0 using open-source software and externally validated it in two unique patient populations, which can be used as a cost-effective option to guide surgical decisions in patients with metastatic bone disease. 相似文献
7.
Evaluation of training nurses to perform semi‐automated three‐dimensional left ventricular ejection fraction using a customised workstation‐based training protocol
下载免费PDF全文
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
8.
9.
10.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255